Obsessive-compulsive disorder (OCD) and major depression, unipolar type (UD), are common, chronic, highly debilitating psychiatric illnesses that have been of great interest to neuroscience for over a century. They exist separately and co-morbidly. Although biological underpinnings are today acknowledged, the brain dysfunctions that may mediate the symptomatic expression of OCD and UD need further clarification. Our (and other) PET studies measuring regional brain glucose metabolic rates implicate an orbital cortical-striatal-thalamic circuit as a possible mediator of the OCD state, while our (and other) PET work implicates lateral prefrontal cortex and caudate nucleus dysfunction in UD. These findings in human functional neuroanatomy warrant intense follow-up, for understanding the pathophysiology of OCD and UD may lead both to new treatment development strategies, and fundamental clues as to how brain mediates complex behavior. This is what motivates this proposal for experiments to further clarify UD and OCD's brain mediation. This proposal's general specific aim is to provide a firm understanding of the different, neuroanatomically organized systems that mediate these two forms of psycho-pathology. Human, rat, and lizard studies that employ PET and autoradiography, along with drug and behavioral manipulations, will be employed to rigorously test specific hypotheses that follow directly from the different cortico-striato-thalamic brain system models of OCD and UD symptom mediation we have proposed. This work is structured as three interactive experiments: l) PET-revealed glucose metabolic rates in UD vs. OCD patients studied pre- and post-treatment with a single agent, paroxetine hydrochloride. 2) Inferior vs. dorsal prefrontal cortex electrical stimulation effects on regional glucose metabolism and behavior in rats; 3) Deoxyglucose autoradiographic studies of cortico-striato- thalamic circuit mediation of social aggressive rituals, and their context-specific behavioral extinction and drug-induced attenuation, in Anolis carolinensis. This work continues and is a logical extension of work on brain systems that may mediate the symptomatic expression of UD and OCD done in this laboratory with NIMH support for l2 years.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH053565-03
Application #
2675293
Study Section
Clinical Neuroscience and Biological Psychopathology Review Committee (CNBP)
Project Start
1996-05-01
Project End
1999-04-30
Budget Start
1998-05-13
Budget End
1999-04-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Radiation-Diagnostic/Oncology
Type
Organized Research Units
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Saxena, Sanjaya; Brody, Arthur L; Maidment, Karron M et al. (2007) Paroxetine treatment of compulsive hoarding. J Psychiatr Res 41:481-7
Saxena, Sanjaya; Brody, Arthur L; Ho, Matthew L et al. (2002) Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 59:250-61
Brody, A L; Saxena, S; Mandelkern, M A et al. (2001) Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry 50:171-8
Saxena, S; Brody, A L; Ho, M L et al. (2001) Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry 50:159-70
Brody, A L; Saxena, S; Stoessel, P et al. (2001) Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 58:631-40
Saxena, S; Rauch, S L (2000) Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 23:563-86
Brody, A L; Saxena, S; Fairbanks, L A et al. (2000) Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine. J Clin Psychiatry 61:349-55
Brody, A L; Saxena, S; Silverman, D H et al. (1999) Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res 91:127-39
Saxena, S; Brody, A L; Maidment, K M et al. (1999) Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 21:683-93
Brody, A L; Saxena, S; Schwartz, J M et al. (1998) FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res 84:1-6

Showing the most recent 10 out of 11 publications